Giulia Mazzaschi

Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

Giulia Mazzaschi, Denise Madeddu, Angela Falco et al. · Clinical Cancer Research · 2017 · 256 citations

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri et al. · European Journal of Cancer · 2020 · 145 citations · Full text

First-line Pembrolizumab, Medicine, Pathology +6

The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC

Giulia Mazzaschi, Francesco Facchinetti, Gabriele Missale et al. · Lung Cancer · 2018 · 132 citations

Advanced Nsclc, Cancer Immunosurveillance, Competent Nk +9

Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients

Giulia Mazzaschi, Roberta Minari, Alessandra Zecca et al. · Lung Cancer · 2020 · 114 citations

Cancer Immunosurveillance, Autoimmune Disease, Allergy +11

Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review

Alessandro Leonetti, Roberta Minari, Giulia Mazzaschi et al. · Frontiers in Oncology · 2021 · 40 citations · Full text